Discovery Partnerships with Academia (DPAc) is an innovative approach to drug discovery. As a unit within GSK’s research and development organization, we’re dedicated to creating highly collaborative relationships with leading academic researchers. We believe that working closely together and combining our different strengths is a great way to develop new medicines that truly benefit patients.
The concept is simple but powerful: bring together the insight and creativity of the academic world with the drug discovery expertise, capabilities and resources needed to make a medicine.
Discovery Partnerships with Academia is a model that is built on the principle that originality, passion, deep knowledge and technical know-how are required to make truly innovative medicines. This needs a partnership between world-class academics and industry-leading drug finders, with each party playing to their strengths and tied together with an agreement that envisions a medicine that benefits patients.
- Patrick Vallance, President
The DPAc approach is different from typical academia-industry collaborations. We love discussing new ideas and providing insightful feedback. When an idea looks promising, we’ll work together to create a mutually beneficial research and funding plan. Learn more